CCM Duopharma Biotech Berhad Through its Subsidiary CCMP Secures LOA from Ministry of Health for RM300 Million Insulin Contract
Kuala Lumpur – CCM Pharmaceuticals Sdn Bhd (CCMP), a subsidiary of CCM Duopharma Biotech Berhad (CCMD), and Biocon Sdn Bhd (a subsidiary of Biocon Ltd) have been awarded a Letter of Award (LOA) by the Ministry of Health (MOH) to supply Human Insulin to all government hospitals and clinics valued at RM300 million for three years until December 1, 2019.